Purpose. In infectious disease therapy, administration of adequate antimicrobial agents is essential for preventing the emergence and spread of resistant bacteria. However, conventional antimicrobial susceptibility testing (AST), based on bacterial growth, is time consuming; therefore, a rapid, simple assay is needed for the timely selection of appropriate antibiotics in clinical laboratories. Here, we established a simple, cost-effective, time-saving and highly sensitive AST assay based on loop-mediated isothermal amplification (LAMP).
INTRODUCTION
The number of fatalities caused by infections due to resistant pathogens is increasing every year [1] . The rise in resistance is mainly caused by the misuse and overuse of antibiotics [1] . Therefore, administration of adequate antibiotics against the target microbe in the treatment of infectious diseases as well as prompt antimicrobial susceptibility testing (AST) in a microbiology laboratory are essential [1] [2] [3] . However, conventional AST in a routine laboratory setting is time consuming [4] . Therefore, patients often require empirical therapy with broad-spectrum antibiotics until resistance or susceptibility is determined in a clinical laboratory.
Recently, some time-saving AST methods have been developed to detect antimicrobial resistance. One of these methods involves detecting particular resistance genes that have been identified using molecular approaches [5, 6] . These methods can be used to rapidly detect resistance genes; however, they do not reflect phenotypic resistance [7, 8] . In contrast, there are other methods that detect phenotypic susceptibility under antibiotic exposure. These other methods are based on gene amplification [9] [10] [11] [12] , magnetic bead biosensors [13] , surface-enhanced Raman spectroscopic biomarkers [14] , and single cell morphological analysis [15, 16] . However, these phenotypic AST methods are costly and complex and are thus, challenging to perform in resource-limited laboratory settings. Therefore, other rapid, simple and cost-effective assays are needed to complement conventional methods.
The loop-mediated isothermal amplification (LAMP) assay is a favoured molecular diagnostic method that is performed under isothermal conditions with Bst DNA polymerase and four or six independent primers that recognize at least six distinct sequences on the target DNA [17] . Since DNA amplification is directly correlated with the turbidity derived from magnesium pyrophosphate, real-time measurement of the LAMP reaction is possible [18] . The advantages of the LAMP are that it is simple, sensitive and cost effective [19] . In addition, this assay does not require expensive equipment and a laboratory environment [19] . The amplification and manipulation capability of LAMP assay are greater than those of traditional detection methods, such as PCR [19] . However, phenotypic AST with a LAMP-based assay has not been reported.
Here, we established a novel phenotypic LAMP-based AST assay and compared the LAMP-based method to the conventional method. This simple AST can detect resistant strains with high sensitivity and specificity, and a significant time advantage.
METHODS
An outline of this method is shown in Fig. 1 . Bacterial samples were cultivated for a short period of time in the presence or absence of antibiotic before use in the LAMP reaction. The time required to detect a positive reaction in the LAMP assay was recorded as the threshold time (Tt) value. Tt values were negatively correlated with the concentration (c.f.u. ml À1 ) of bacteria (Fig. 2) . We subtracted the Tt value for the antibiotic-free sample from the Tt value for the antibiotic-exposed sample, and we used the DTt value as a marker of microbial susceptibility (Fig. 1) . The Tt values of resistant strains were unchanged, despite antibiotic exposure. In resistant samples, the Tt values with and without antibiotics were comparable, and the DTt value was lower than that in susceptible strains.
Bacterial isolates
Escherichia coli ATCC 25922 was obtained from American Type Culture Collection (Manassas, VA, USA) and was used as a drug-sensitive control strain. We analysed 46 E. coli strains that were isolated from clinical specimens (38 urine and eight other samples) obtained from patients at Hamamatsu University School of Medicine, Shizuoka, Japan (Table S1 , available in the online version of this article). The sources of the samples we used were most urine from patients with urinary tract infection (UTI) in this study. All strains were identified by 16S rRNA sequencing using universal primers [20] . DNA extraction and purification were performed with the NucleoSpin Microbial DNA kit (TaKaRa, Tokyo, Japan) according to the manufacturer's instructions. The 16S rRNA genes were directly sequenced using the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster, CA, USA) with a 3500 Series Genetic Analyzer (Applied Biosystems). The sequence data were compared to the International Nucleotide Sequence Database by using the Ribosomal Database Project (http://rdp.cme.msu.edu/seqmatch/seqmatch_intro.jsp). Extended spectrum b-lactamase (ESBL)-encoding genes Fig. 1 . Schematic of the LAMP-based AST. Bacterial strains were incubated in the presence or absence of antibiotic (±AB) at 36 C, with shaking. The time threshold (Tt) value of each culture was measured by LAMP, and the DTt value, which is the Tt value without AB subtracted from the Tt value with AB, was determined. We analysed the DTt value of bacterial strains with and without AB.
of all clinical isolates were detected by PCR amplification for bla genes using specific primers for bla SHV /bla-TEM /bla OXA-1 -like genes, and bla CTX-M genes including phylogenetic groups 1, 2 and 9, as reported previously [21] . In total, 19 of 46 strains had ESBL-encoding genes, and six among them owned two or more of the genes (Table S1 ). The CTX-M-1 was most frequently detected. We also confirmed no production of enterohemolysin from all strains by enterohemolysin test agar plates (Kyokuto, Tokyo, Japan). The isolates we used in this study were not enterohemorrhagic E. coli pathotype.
Conventional broth microdilution test
The broth microdilution (BMD) method was performed according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI) [22] . Each clinical isolate was plated on blood agar and incubated at 36 C overnight. The 96-well MicroScan panels (Beckmann Coulter, Krefeld, Germany) were inoculated with each isolate to yield the appropriate density of 10 5 c.f.u. ml À1 and incubated for 16 to 20 h at 35 C in ambient air. The MICs were determined by the MicroScan WalkAway 96 Plus system (Beckmann Coulter). The susceptible, intermediate or resistance (SIR) categories were based on CLSI document M100-S25 [23] .
LAMP assay DNA extraction and reagent preparation for the gene amplification were carried out using the Loopamp Specified Micro-organism 'Bacteria Multi4' Detection Kit (BM4; Eiken Chemical, Tokyo, Japan), which detects four species of bacteria: E. coli, Staphylococcus aureus, Pseudomonas aeruginosa and Salmonella spp., from cultured broth or clinical samples, according to the manufacturer's instructions. Briefly, extraction reagent was added to the liquid culture medium and heated at 95 C for 20 min. Then, the processing solution and primer mix were pipetted into the solidphase DNA Amplification Reagent, and the mixture was incubated at 61 C for 60 min. A positive reaction was detected by real-time turbidity detection with Loopamp EXIA (Eiken Chemical).
Optimization of LAMP-based AST
We selected levofloxacin (LVFX) and ampicillin (ABPC; Wako Pure Chemical Industries, Osaka, Japan) as the test antibiotics, which are frequently used for the treatment of UTIs. We constructed an experimental system for E. coli ATCC 25922 and a clinical strain, EC5, which were sensitive and resistant to antibiotics, respectively. We supplemented Mueller-Hinton broth (Difco Laboratories, Detroit, MI, USA) with and without antibiotics at final concentration of 2.0 µg ml À1 for LVFX or 16 µg ml À1 for ABPC, both of which are breakpoints for E. coli. Fresh bacterial colonies were suspended in each broth, and these prepared media were incubated at 36 C with shaking. Bacterial DNA from the culture solution was amplified by LAMP. We assessed the optimal bacterial concentration (6.0Â10 5 , 6.0Â10 6 and 6.0Â10 7 c.f.u. ml
À1
) and incubation time (every hour for a total incubation time of 4 h) in triplicate.
Detection of resistant strains by optimized LAMPbased AST
We examined the antimicrobial susceptibility of clinical isolates of E. coli by using the optimized LAMP-based AST. We selected LVFX, ABPC, trimethoprim-sulfamethoxazole (ST) and fosfomycin (FOM) (Wako Pure Chemical Industries) for detecting resistant strains. It was often reported that E. coli strains isolated from patients with UTIs are resistant to those antibiotics [24] [25] [26] . The final concentrations that we used in this study were 38.0 µg ml À1 for sulfamethoxazole, 2 µg ml À1 for trimethoprim or 4 µg ml À1 for FOM. We evaluated the sensitivity and specificity of the LAMPbased method compared to the conventional BMD assay for detecting resistant E. coli strains by receiver operating characteristic (ROC) curve analysis. However, we used the FOM breakpoint recommended by Beckman Coulter, not CLSI, for determining susceptibility of E. coli, because there has been a paucity of published CLSI reference method in vitro FOM-AST data available [23] .
Statistical analysis
Statistical analyses were performed using GraphPad Prism ver. 7.03 (GraphPad Software, San Diego, CA, USA). Data are expressed as the mean±SEM. Statistical evaluation of the differences between the means of experimental groups was performed by the Wilcoxon/Kruskal-Wallis test. Spearman's rank correlation analysis was used to determine the relationships between Tt values and bacterial concentration. P-values less than 0.05 were considered significant. 
RESULTS
Tt values determined by the LAMP assay are negatively correlated with the concentration of bacteria We first confirmed the relationship between the concentration of bacteria and the Tt value. Tenfold serial dilutions were made of a culture of E. coli ATCC 25922 in MuellerHinton broth (2.0Â10 9 c.f.u. ml À1 ) and was assessed by the LAMP assay using the BM4 (Fig. 2) . LAMP-amplified products could not be detected with less than 2.0Â10 5 c.f.u. ml
À1
of E. coli ATCC 25922. At 2.0Â10 6 -2.0Â10 9 c.f.u. ml À1 , Spearman's rank correlation analysis showed that the Tt values were negatively correlated with the concentration of bacteria (r=À0.8083, P=0.0015). These results indicated that the Tt value depends on the bacterial concentration.
Optimization of the LAMP assay for DTt values As the first step toward a standardized method, we determined that the optimal bacterial concentration was reached after 2 h of incubation. Antibiotic-sensitive and -resistant strains could be distinguished at concentrations of 6.0Â10 6 and 6.0Â10 7 c.f.u. ml À1 in both the LVFX and ABPC exposure assays (Fig. 3a, b) . Next, we evaluated the DTt values for various incubation times at a bacterial concentration of 6.0Â10 6 c.f.u. ml
. These results showed a significant Fig. 3 . E. coli ATCC 25922 (MIC: LVFX 0.5 µg ml À1 , ABPC 8 µg ml À1 ; grey bars) and clinical strain EC5 (MIC: LVFX>4 µg ml À1 , ABPC>16 µg ml À1 ; black bars) were analysed to determine the optimal conditions for the E. coli-LAMP assay. Antibiotics were added at a final concentration of 2.0 µg ml À1 for LVFX (a, c) or 16 µg ml À1 for ABPC (b, d). Mueller-Hinton broth containing serial dilutions of bacteria (6.0Â10 5 , 6 .0Â10 6 and 6.0Â10 7 c.f.u. ml À1 ) were incubated in the presence or absence of antibiotics for 2 h (a, b). Then, the cell density was adjusted to 6.0Â10 6 c.f.u. ml À1 , and the bacteria were cultivated for 1, 2, 3 and 4 h (c, d). We analysed the DTt value, which is the Tt value in antibiotic-free medium subtracted from the Tt value in LVFX-or ABPC-containing medium determined by the LAMP assay. Negative DTt values are reported as zero. Data are presented as mean±SEM (n=3). The statistical analysis was performed using the Wilcoxon/Kruskal-Wallis test, *P<0.05, **P<0.01, ***P<0.005. difference between susceptible and resistant strains after culturing with antibiotics for more than 2 h (Fig. 3c, d ). The optimal conditions for the LAMP assay and the DTt values were 6.0Â10 6 c.f.u. ml À1 of inoculum and 2 h of incubation with antibiotic.
DTt values obtained using the optimized LAMPbased assay simply and quickly detect microbial resistance in clinical samples In total, 46 clinical isolates were used in this study. Antimicrobial susceptibility profiling of the strains was performed by both the optimized LAMP-based assay and BMD (Tables  1 and S1 ), and no isolates were intermediate to other antibiotics in this study. Using the LAMP-based method, the DTt values in LVFX-susceptible strains were widely distributed from +114 to +666 s, whereas the DTt values in resistant strains were regularly distributed from À114 to +90 s (Fig. 4a) . Therefore, the cutoff for detecting LVFX resistance was set at 100 s. In the ROC analysis, susceptibility to LVFX using the DTt value perfectly matched with the results of conventional BMD (area under the ROC curve=1.00; Fig. 4b ). In addition, the DTt values of ABPCsusceptible strains ranged from +66 to +276 s, whereas those of resistant strains ranged from À216 to +78 s (Fig. 4c) . Using an ABPC susceptibility threshold of 100 s, the sensitivity and specificity for detecting ABPC resistance were 100 and 80.0 %, respectively, with positive predictive value (PPV) and negative predictive value (NPV) of 91.2 and 100 %, respectively. In the ROC analysis for identifying ABPC resistance, the area under the curve (AUC) was 0.99 (Fig. 4d) . Furthermore, the DTt values of ST and FOM susceptible strains ranged from +42 to +452 and +72 to +480 s, whereas those of resistant strains ranged from À414 to +102 and À348 to +72 s, respectively (Figs S1a and S1c). In intermediate categories to FOM, the DTt values of two isolates were +210 and +300 s like susceptible strain pattern. Using the same susceptibility threshold, the sensitivity, specificity, PPV and NPV for detecting ST and FOM resistance were 93.8 %, 93.3 %, 88.2 % and 96.6 % and 100 %, 97.6 %, 83.3 % and 100 %, respectively. In the ROC analysis for detecting ST and FOM resistance, the AUC were 0.99 and 1.00, respectively (Figs S1b and S1d).
DISCUSSION
Here, we assessed a novel diagnostic method using LAMP for rapid bacterial AST. This phenotypic AST based on bacterial growth can detect microbial resistance and can be used to select the appropriate antibiotics. The assay is simple, accurate and low-cost, and the whole test process can be performed within 4 h. Therefore, using the LAMP-based phenotypic assay, the susceptibility profile might be reported sooner.
LAMP is a new DNA amplification method in which a gene can be detected in a single step, by incubating a mixture of the sample and test reagents at a constant temperature [17] . It shows high amplification efficiency, and DNA is amplified 10 9 -10 10 times in 15-60 min [17] . Therefore, gene detection assays using LAMP have been used for the rapid identification of toxin-encoding genes, molecular serotypes and resistance genes [27] [28] [29] . However, there are few reports evaluating the amplification time for detecting a positive reaction by LAMP. Schoepp et al. determined the susceptibility profile using a digital LAMP assay by measuring the phenotypic response of E. coli under antibiotic exposure [12] . The assay could measure clinical specimens directly, with 96.3 % categorical agreement of susceptibility determination (susceptible or resistant). Although the accuracy of their AST was comparable to our method, it was costly and complex, and the digital LAMP assay required specialized equipment. Thus, we established a simple, lowcost LAMP-based AST to complement the digital LAMP method.
Regarding the initial equipment cost, the turbidimeter (Eiken Chemical LoopampEXIA 2,000,000 JPY) is much lower cost than the micro-organism identification and susceptibility testing system for conventional BMD assay (Beckman Coulter, MicroScan WalkAway 96 Plus system 33,000,000 JPY). On the other hand, the cost of each trial in LAMP-based AST depends on number of types of antibiotics. At the current point in time, the cost of evaluating three antimicrobials in each assay is comparable to that of each trial in conventional BMD (1800 to 2000 JPY per trial). Basically, LAMP-based AST is a more cost effective method than conventional BMD assay. However, we think that LAMP-based methods will be more cost effective per each assay after spread of them, we might be able to examine more antimicrobial agents in the near future.
In recent years, microchip and microdevice technologies for automation have been developed in the field of genetic testing via isothermal amplification [30] . Real-time LAMPbased automated platforms have significant capability for commercialization due to their low cost and the absence of a need for skilled operators [30] . In addition, Kostić et al. reported a novel LAMP-based method with the Gene-Z card, which is operated using a smartphone via a Wi-Fi interface [31] . By taking advantage of these techniques, we might be able to reduce the operation time of our LAMPbased AST and use it for point-of-care testing in clinical settings.
UTIs are one of the most common bacterial infections worldwide. E. coli is the most frequent cause of UTIs, and fluoroquinolones, such as LVFX, and beta-lactams, including ABPC, are widely used to treat UTIs caused by E. coli. However, the rates of resistance to these agents have been gradually increasing [24] [25] [26] 32] . Therefore, selection of appropriate antibiotics is key for empirical treatment of the infection. In this study, we examined a LAMP-based AST for resistance to LVFX, ABPC, ST and FOM, which have been commonly used to treat UTI in the world. This method showed high sensitivity for four antibiotics; however, there was a more obvious difference in the Tt value In this study, only two strains were intermediate to FOM and the both DTt values were surprisingly over 200 s like susceptible strain pattern. As the reason for that, we have used the FOM breakpoint recommended by Beckman Coulter, not CLSI, for determining susceptibility of E. coli. The CLSI agar dilution method for FOM-AST is complex to use agar supplemented with glucose-6-phospate unlike other antibiotics, thus we have not performed them at our institute. In the near future, we need to improve our measurement system to examine multiple antimicrobial agents and different sensitivity profile strains, such as seven agents with eight-tubes at the same time in routine microbiological laboratories.
One limitation of the study is the small sample size and the use of only four antibiotics. The LAMP primers in BM4, which we used in this study, target four particular bacterial species. In the clinical laboratory, it will be necessary to prepare specific primers that correspond to additional pathogenic micro-organisms. Therefore, in future studies, other primers that cover many types of bacteria will be designed.
In conclusion, we established a simple and accurate LAMPbased AST for detecting antibiotic-resistant E. coli. This method can determine bacterial susceptibility faster than the conventional BMD assay. The reduction in turnaround time achieved by using this LAMP-based AST could improve the clinical management of antimicrobial-resistant bacteria.
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